MalDA, Accelerating Malaria Drug Discovery.

MalDA, Accelerating Malaria Drug Discovery.
复制标题

MalDA,加速疟疾药物发现。

DOI:
10.1016/j.pt.2021.01.009
复制
发表时间:
2021-06
影响因子:
9.6
通讯作者:
Malaria Drug Accelerator Consortium
Malaria Drug Accelerator Consortium
中科院分区:
医学1区
文献类型:
--
作者:
Yang T;Ottilie S;Istvan ES;Godinez-Macias KP;Lukens AK;Baragaña B;Campo B;Walpole C;Niles JC;Chibale K;Dechering KJ;Llinás M;Lee MCS;Kato N;Wyllie S;McNamara CW;Gamo FJ;Burrows J;Fidock DA;Goldberg DE;Gilbert IH;Wirth DF;Winzeler EA;Malaria Drug Accelerator Consortium

文献摘要

参考文献

被引文献

相似文献

疟疾药物加速器(MalDA)是由15个领先的科学实验室组成的联盟。MalDA的目的是通过确定新的、基本的、可药物化的靶点来改善和加速早期抗疟药物发现过程。此外,它还寻求生产早期的先导抑制剂,这些抑制剂可能会进入适合临床前开发和随后的人体临床试验的候选药物。通过共享资源,包括专业知识,知识,材料和试剂,该联盟致力于消除药物发现过程中经常遇到的结构性障碍。在这里,我们讨论了该财团的使命及其科学成就,包括新的化学和生物学验证的目标,以及未来的科学方向的识别。
The Malaria Drug Accelerator (MalDA) is a consortium of 15 leading scientific laboratories. The aim of MalDA is to improve and accelerate the early antimalarial drug discovery process by identifying new, essential, druggable targets. In addition, it seeks to produce early lead inhibitors that may be advanced into drug candidates suitable for preclinical development and subsequent clinical testing in humans. By sharing resources, including expertise, knowledge, materials, and reagents, the consortium strives to eliminate the structural barriers often encountered in the drug discovery process. Here we discuss the mission of the consortium and its scientific achievements, including the identification of new chemically and biologically validated targets, as well as future scientific directions.
DOI: 10.1073/pnas.1414221111
发表时间: 2014-12-16
影响因子: 11.1
作者:
Belen Jimenez-Diaz, Maria;Ebert, Daniel;Guy, R. Kiplin
通讯作者: Guy, R. Kiplin
DOI: 10.1016/j.bmcl.2011.07.044
发表时间: 2011-09-15
影响因子: 2.7
作者:
Bueno, Jose M.;Manzano, Pilar;Gargallo-Viola, Domingo
通讯作者: Gargallo-Viola, Domingo
DOI: 10.1038/s41467-017-00572-x
发表时间: 2017-09-05
影响因子: 16.6
作者:
Baker DA;Stewart LB;Large JM;Bowyer PW;Ansell KH;Jiménez-Díaz MB;El Bakkouri M;Birchall K;Dechering KJ;Bouloc NS;Coombs PJ;Whalley D;Harding DJ;Smiljanic-Hurley E;Wheldon MC;Walker EM;Dessens JT;Lafuente MJ;Sanz LM;Gamo FJ;Ferrer SB;Hui R;Bousema T;Angulo-Barturén I;Merritt AT;Croft SL;Gutteridge WE;Kettleborough CA;Osborne SA
通讯作者: Osborne SA
DOI: 10.1038/s41467-018-05777-2
发表时间: 2018-09-18
影响因子: 16.6
作者:
Delves, Michael J.;Miguel-Blanco, Celia;Baum, Jake
通讯作者: Baum, Jake
DOI: 10.1038/ncomms1522
发表时间: 2011-11-01
影响因子: 16.6
作者:
Bhatt, Tarun Kumar;Khan, Sameena;Sharma, Amit
通讯作者: Sharma, Amit